With the cumulative clinical evidence, it is justifiable to suppose that CEA, CA19-9 and CA72-4 could be used conjunctively in reflecting tumor burden for LAGC and predicting prognosis [31, 32]. Here, CEACAM5 is linked to neoplasm.